Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04627428 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Luxa Biotechnology, LLC |
| Last Updated on CT.gov | October 15, 2025 (Oct 15, 2025) |
As of March 2, 2026: Clinical trial NCT04627428 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 3 locations across the United States. The study is sponsored by Luxa Biotechnology, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04627428 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04627428 was last updated Oct 15, 2025 (October 15, 2025). HelloStudys verifies this status automatically.